CMP
CVS icon

Coston McIsaac & Partners’s CVS Health CVS Stock Holding History

Coston McIsaac & Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91K Sell
887
-51
-5% -$4.55K 0.02% 246
2026
Q1 		$67K Sell
938
-54
-5% -$4.16K 0.02% 282
2025
Q4 		$78K Sell
992
-195
-16% -$15.4K 0.02% 251
2025
Q3 		$89K Buy
1,187
+4
+0.3% +$274 0.02% 237
2025
Q2 		$81K Buy
1,183
+6
+0.5% +$393 0.02% 234
2025
Q1 		$79K Buy
1,177
+7
+0.6% +$419 0.02% 217
2024
Q4 		$52K Buy
1,170
+8
+0.7% +$449 0.02% 268
2024
Q3 		$73K Buy
1,162
+93
+9% +$5.43K 0.02% 227
2024
Q2 		$63K Buy
1,069
+345
+48% +$21.6K 0.02% 230
2024
Q1 		$57K Buy
724
+185
+34% +$14.1K 0.02% 249
2023
Q4 		$42K Buy
539
+161
+43% +$11.5K 0.01% 286
2023
Q3 		$26K Buy
378
+3
+0.8% +$213 0.01% 343
2023
Q2 		$25K Buy
375
+3
+0.8% +$213 0.01% 378
2023
Q1 		$27K Buy
372
+2
+0.5% +$168 0.01% 363
2022
Q4 		$34K Buy
370
+2
+0.5% +$193 0.01% 335
2022
Q3 		$35K Buy
368
+1
+0.3% +$99 0.02% 269
2022
Q2 		$34K Buy
+367
New +$35.8K 0.02% 166

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Coston McIsaac & Partners's CVS Position: Q2 2026 in Review

Coston McIsaac & Partners reduced its CVS Health (CVS) stake by 5.4% in Q2 2026, selling an estimated $4.55K and leaving 887 shares worth $91K. The position accounts for 0.02% of the portfolio, ranked #246.

Coston McIsaac & Partners first reported a position in CVS in Q2 2022 and has held it in 17 quarters since. 2,070 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Coston McIsaac & Partners held 887 shares of CVS Health worth $91K as of Q2 2026.
  • Coston McIsaac & Partners sold 51 CVS Health shares in Q2 2026, an estimated $4.55K.
  • CVS Health made up 0.02% of Coston McIsaac & Partners's portfolio in Q2 2026, its #246 holding.
  • Coston McIsaac & Partners first reported a position in CVS Health in Q2 2022 and has held it in 17 quarters since.
  • 2,070 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.